Incorrect username and/or password, please try again or click to reset.

Class 2 Medicines Recall: Hikma Pharmaceuticals USA Inc, Lorazepam 2mg/ml Injection, Lorazepam 4mg/ml Injection (unlicensed medicines)

2022-08-30 10:00:10 (2 year(s) ago)


Hikma Pharmaceuticals USA Inc are recalling the below batches due to an out of specification result with related substances during testing for retain samples.

Read full MHRA article

Respond to this alert